NoBACZ
NoBACZ Healthcare is already redefining topical veterinary care with its first technology platform: durable, flexible liquid and gel barriers that create instant protective environments, accelerating healing and reducing infection risk across livestock and equine.
A Cambridge University spin‑out founded in 2020, we deliver sustainable, easy‑to‑use products that support the global effort to reduce unnecessary antibiotic use and combat AMR. Our first platform is already proven in real‑world conditions, showing strong field performance and clear commercial traction. With three products launched across 14 countries and circa 6 million doses sold, NoBACZ combines scientific credibility with robust distributor economics. Having surpassed our first £1 million in annual revenue after a successful £4.8 million raise in summer 2025, we are now expanding the pipeline built on this success.